This article documents quantitative changes in the size of a periocular capillary hemangioma using sequential echographic testing in a patient receiving off-label treatment with systemic propranolol therapy. The patient presented at 7 weeks old with a right periocular capillary hemangioma. Systemic propranolol therapy was elected. Diagnostic B-scan and quantitative A-scan echography documented the lesion size at presentation as 22.3 mm in greatest dimension. The tumor decreased in size to 20.0 mm after 21/2 weeks of treatment and 16.0 mm after 61/2 weeks of treatment. No adverse side effects have been noted. Echography is an excellent modality for documenting the regression of periocular capillary hemangiomas during treatment with systemic propranolol.
|Original language||English (US)|
|Journal||Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye|
|State||Published - May 16 2011|
ASJC Scopus subject areas